Holland Capital invests in Pluggerz 

Amsterdam, Doetinchem, 11th of March 2026 –  Holland Capital invests in Pluggerz, a market leader in custom-made hearing protection. Through this partnership, Pluggerz will be able to further strengthen its position and respond to the structurally increasing demand for hearing protection solutions.

Regulation and prevention awareness drive structural market growth

The market for hearing protection is growing, driven by stricter regulations regarding workplace noise exposure and the increasing responsibility of employers to actively prevent hearing damage. At the same time, societal awareness around hearing loss is increasing. Younger generations in particular are increasingly choosing structural protection.

Custom-made hearing protection

Pluggerz has been the hearing protection specialist of the Netherlands for 40 years and is the market leader in custom-made hearing protection. In addition, the company produces universal  hearing protection and components for hearing aids. The organization combines high-quality customized products with advanced 3D printing technology, in-house R&D, and close collaboration with audiologists for personal fitting.

Investment for growth

The investment by Holland Capital enables Pluggerz to solidify its positions as market leader and invest strategically to fully benefit from the growing demand for hearing protection products.

Hubert Verbeek, Managing Partner Holland Capital: “We look forward to supporting Pluggerz in its development and contributing to the broader adoption of hearing protection. With our Healthcare and Technology expertise, we can help Pluggerz realize commercial acceleration and sustainable value creation.”

About Pluggerz

Pluggerz employs more than 90 people and operates from Doetinchem, where production and office activities take place under one roof. From its own production facilities, the company delivers quickly and efficiently to customers both domestically and internationally. Pluggerz develops and produces components for hearing aids and universal hearing protection for audiology, retail, and industrial clients. In addition, the organization collaborates with a social workshop and actively contributes to inclusive and sustainable employment in the region.

About Holland Capital

For more than 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the shared goal of realizing growth. Holland Capital has offices in Amsterdam and Düsseldorf. With specialized sector teams, it focuses on the Healthcare and Technology sectors. The firm understands the dynamics and opportunities in these sectors and has an extensive network.

The Key Information Document (KID) of this transaction in Dutch can be found here.

 

Holland Capital investeert in Health IT-bedrijf Open HealthHub

Holland Capital investeert in Health IT-bedrijf Open HealthHub

Amsterdam, 26 juli 2022 – Holland Capital investeert in Open HealthHub, een digitaal platform waarmee zorgverleners en patiënten veilig en vertrouwd medische gegevens kunnen uitwisselen om administratieve lasten voor zorgverleners te verminderen. De investering wordt...

Holland Capital invests in Health IT company Open HealthHub

Holland Capital invests in Health IT company Open HealthHub

Amsterdam, 26 July 2022 – Holland Capital is investing in Open HealthHub, a digital platform that allows healthcare providers and patients to exchange medical data safely and securely. It will also reduce the administrative burden on healthcare providers. The...

Mauritskliniek intends to join Corius

Mauritskliniek intends to join Corius

Amsterdam, 21 July 2022 – Our portfolio company Mauritskliniek intends to join Corius. Mauritskliniek provides healthcare services in dermatology, varicose veins, proctology, skin therapy and medical-cosmetic care. The Mauritskliniek is located in Amsterdam, The...

Mauritskliniek is voornemens zich aan te sluiten bij Corius

Mauritskliniek is voornemens zich aan te sluiten bij Corius

Amsterdam, 21 juli 2022 – Onze deelneming Mauritskliniek is voornemens zich aan te sluiten bij Corius. Mauritskliniek (incl. Kliniek Veldhoven) is  als keten van focusklinieken gerenommeerd voor zorg op het gebied van dermatologie, flebologie (spataderzorg),...

Holland Capital realizes successful exit of Humeca to i4hi

Holland Capital realizes successful exit of Humeca to i4hi Borne / Amsterdam, 5 July 2022 – Investment company Holland Capital realizes a successful exit of Humeca to fellow investor i4hi. Humeca is a leading supplier of innovative products in the field of advanced...

Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411

 

Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120

Contact
info@hollandcapital.nl